Biggest News Aggregation in the World
📰 Allogeneic News

Page 4 - Allogeneic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allogeneic. Real-time updates on events, politics, business and more.

Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic preclinical model in vivo, including following tumor cell... | April 13, 2023
United Kingdom Steve Harr Immunocompetent Allogeneic Sana Biotechnology Inc Company Securities Exchange Commission

Precision BioSciences Receives U.S. and International Patent Allowances for Proprietary PCSK9 ARCUS Nuclease

Precision BioSciences, Inc. , a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced it has received a Notice... | April 13, 2023
Michael Amoroso Jeff Smith Trademark Office Precision Biosciences Inc Precision Biosciences Chief Research Officer

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -ROCKVILLE, Md., April 13, 2023 (GLOBE NEWSWIRE)
United States Theriva Biologics Erikr Dubberke Chris Calabrese Bella Centre Copenhagen Theriva Biologics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the immune system Similar hypoimmune primary human... | April 12, 2023
United Kingdom Steve Harr Exchange Commission Sana Biotechnology Inc Company Securities Science Translational Medicine

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and... | March 31, 2023
Compensation Committee Of Atara Board Directors Atara Biotherapeutics Inc Compensation Committee Nasdaq Listing Rule Atara Biotherapeutics Nc Stock Exchange

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science